Palatnik A, Moosreiner A, Olivier-Van Stichelen S.

REPLY: Consumption of non-nutritive sweeteners during pregnancy.

Am J Obstet Gynecol. 2020 Aug 13:S0002-9378(20)30853-X. doi: 10.1016/j.ajog.2020.08.025. Epub ahead of print. PMID: 32800821.

Palatnik A, Moosreiner A, Olivier-Van Stichelen S.

REPLY: Consumption of non-nutritive sweeteners during pregnancy.

Am J Obstet Gynecol. 2020 Aug 12:S0002-9378(20)30849-8. doi: 10.1016/j.ajog.2020.08.021. Epub ahead of print. PMID: 32795429.

Palatnik A, Moosreiner A, Olivier-Van Stichelen S.

Consumption of non-nutritive sweeteners during pregnancy.

Am J Obstet Gynecol. 2020 Aug;223(2):211-218. doi: 10.1016/j.ajog.2020.03.034. Epub 2020 Apr 8. PMID: 32275895.

Olivier-Van Stichelen S, Rother KI, Hanover JA.

Maternal Exposure to Non-nutritive Sweeteners Impacts Progeny's Metabolism and Microbiome.

Front Microbiol. 2019 Jun 20;10:1360. doi: 10.3389/fmicb.2019.01360. PMID: 31281295; PMCID: PMC6595049.

Akan I, Olivier-Van Stichelen S, Bond MR, Hanover JA.

Nutrient-driven O-GlcNAc in proteostasis and neurodegeneration.

J Neurochem. 2018 Jan;144(1):7-34. doi: 10.1111/jnc.14242. Epub 2017 Nov 20. PMID: 29049853; PMCID: PMC5735008.

Olivier-Van Stichelen S, Wang P, Comly M, Love DC, Hanover JA.

Nutrient-driven O-linked N-acetylglucosamine (O-GlcNAc) cycling impacts neurodevelopmental timing and metabolism.

Biol Chem. 2017 Apr 14;292(15):6076-6085. doi: 10.1074/jbc.M116.774042. Epub 2017 Feb 28. PMID: 28246173; PMCID: PMC5391740.

Baldini SF, Steenackers A, Olivier-Van Stichelen S, Mir AM, Mortuaire M, Lefebvre T, Guinez C.

Glucokinase expression is regulated by glucose through O-GlcNAc glycosylation.

Biochem Biophys Res Commun. 2016 Sep 16;478(2):942-8. doi: 10.1016/j.bbrc.2016.08.056. Epub 2016 Aug 9. PMID: 27520373.

Steenackers A, Olivier-Van Stichelen S, Baldini SF, Dehennaut V, Toillon RA, Le Bourhis X, El Yazidi-Belkoura I, Lefebvre T.

Silencing the Nucleocytoplasmic O-GlcNAc Transferase Reduces Proliferation, Adhesion, and Migration of Cancer and Fetal Human Colon Cell Lines.

Front Endocrinol (Lausanne). 2016 May 25;7:46. doi: 10.3389/fendo.2016.00046. PMID: 27252680; PMCID: PMC4879930.

Olivier-Van Stichelen S, Hanover JA.

You are what you eat: O-linked N-acetylglucosamine in disease, development and epigenetics.

Curr Opin Clin Nutr Metab Care. 2015 Jul;18(4):339-45. doi: 10.1097/MCO.0000000000000188. PMID: 26049631; PMCID: PMC4479189.

Olivier-Van Stichelen S, Hanover JA.

X-inactivation normalizes O-GlcNAc transferase levels and generates an O-GlcNAc-depleted Barr body.

Front Genet. 2014 Aug 4;5:256. doi: 10.3389/fgene.2014.00256. PMID: 25136351; PMCID: PMC4120696.

Abramowitz LK, Olivier-Van Stichelen S, Hanover JA.

Chromosome imbalance as a driver of sex disparity in disease.

J Genomics. 2014 Apr 1;2:77-88. doi: 10.7150/jgen.8123. PMID: 25031659; PMCID: PMC4091450.

Olivier-Van Stichelen S, Abramowitz LK, Hanover JA.

X marks the spot: does it matter that O-GlcNAc transferase is an X-linked gene?

Biochem Biophys Res Commun. 2014 Oct 17;453(2):201-7. doi: 10.1016/j.bbrc.2014.06.068. Epub 2014 Jun 21. PMID: 24960196; PMCID: PMC4253714.

Perez-Cervera Y, Dehennaut V, Aquino Gil M, Guedri K, Solórzano Mata CJ, Olivier-Van Stichelen S, Michalski JC, Foulquier F, Lefebvre T.

Insulin signaling controls the expression of O-GlcNAc transferase and its interaction with lipid microdomains.

FASEB J. 2013 Sep;27(9):3478-86. doi: 10.1096/fj.12-217984. Epub 2013 May 20. PMID: 23689613.

Drougat L, Olivier-Van Stichelen S, Mortuaire M, Foulquier F, Lacoste AS, Michalski JC, Lefebvre T, Vercoutter-Edouart AS.

Characterization of O-GlcNAc cycling and proteomic identification of differentially O-GlcNAcylated proteins during G1/S transition.

Biochim Biophys Acta. 2012 Dec;1820(12):1839-48. doi: 10.1016/j.bbagen.2012.08.024. Epub 2012 Sep 3. PMID: 22967762.

Olivier-Van Stichelen S, Drougat L, Dehennaut V, El Yazidi-Belkoura I, Guinez C, Mir AM, Michalski JC, Vercoutter-Edouart AS, Lefebvre T.

Serum-stimulated cell cycle entry promotes ncOGT synthesis required for cyclin D expression.

Oncogenesis. 2012 Dec 10;1(12):e36. doi: 10.1038/oncsis.2012.36. PMID: 23552487; PMCID: PMC3545199.

Olivier-Van Stichelen S, Guinez C, Mir AM, Perez-Cervera Y, Liu C, Michalski JC, Lefebvre T.

The hexosamine biosynthetic pathway and O-GlcNAcylation drive the expression of β-catenin and cell proliferation.

Am J Physiol Endocrinol Metab. 2012 Feb 15;302(4):E417-24. doi: 10.1152/ajpendo.00390.2011. Epub 2011 Nov 22. PMID: 22114026.

Olivier S, Mir AM, Michalski JC, Lefebvre T.

[Signaling and metabolic predispositions linked to the colorectal cancer] (French)

Med Sci (Paris). 2011 May;27(5):514-20. French. doi: 10.1051/medsci/2011275017. Epub 2011 May 25. PMID: 21609673.

Lefebvre T, Dehennaut V, Guinez C, Olivier S, Drougat L, Mir AM, Mortuaire M, Vercoutter-Edouart AS, Michalski JC

Dysregulation of the nutrient/stress sensor O-GlcNAcylation is involved in the etiology of cardiovascular disorders, type-2 diabetes and Alzheimer's disease

Biochim Biophys Acta. 2010 Feb;1800(2):67-79. doi: 10.1016/j.bbagen.2009.08.008. Epub 2009 Sep 2. PMID: 19732809

©2020 by Olivier-Van Stichelen. Content is not supported nor pre-approved by the Medical College of Wisconsin.